| Name | {5-[(Z)-{2-[(4-Fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4(3H)-pyrimidinylidene}amino]-2-oxo-1,3-benzoxazol-3(2H)-yl}methyl dihydrogen phosphate | 
|---|---|
| Synonyms | 2(3H)-Benzoxazolone, 5-[[(4Z)-2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4(3H)-pyrimidinylidene]amino]-3-[(phosphonooxy)methyl]- {5-[(Z)-{2-[(4-Fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4(3H)-pyrimidinylidene}amino]-2-oxo-1,3-benzoxazol-3(2H)-yl}methyl dihydrogen phosphate | 
| Description | Fosifidancitinib is a potent and selective inhibitor of JAK kinases 1/3. Fociatinib is used in studies of allergies, asthma and autoimmune diseases[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.6±0.1 g/cm3 | 
|---|---|
| Boiling Point | 723.1±70.0 °C at 760 mmHg | 
| Molecular Formula | C21H21FN5O7P | 
| Molecular Weight | 505.39 | 
| Flash Point | 391.1±35.7 °C | 
| Exact Mass | 505.116272 | 
| LogP | 2.15 | 
| Vapour Pressure | 0.0±2.5 mmHg at 25°C | 
| Index of Refraction | 1.680 |